These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes. Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180 [TBL] [Abstract][Full Text] [Related]
4. Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector. Choi SH; Lee HC Gene Ther; 2011 Feb; 18(2):155-63. PubMed ID: 20720576 [TBL] [Abstract][Full Text] [Related]
5. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice. Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856 [TBL] [Abstract][Full Text] [Related]
7. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats. Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525 [TBL] [Abstract][Full Text] [Related]
9. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice. Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370 [TBL] [Abstract][Full Text] [Related]
10. Prolonged remission of diabetes by regeneration of beta cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1. Liu MJ; Shin S; Li N; Shigihara T; Lee YS; Yoon JW; Jun HS Mol Ther; 2007 Jan; 15(1):86-93. PubMed ID: 17164779 [TBL] [Abstract][Full Text] [Related]
11. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats. Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Green BD; Gault VA; O'Harte FP; Flatt PR Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953 [TBL] [Abstract][Full Text] [Related]
13. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
14. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Tonne JM; Sakuma T; Deeds MC; Munoz-Gomez M; Barry MA; Kudva YC; Ikeda Y Dis Model Mech; 2013 Sep; 6(5):1236-45. PubMed ID: 23828045 [TBL] [Abstract][Full Text] [Related]
15. A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice. Sagazio A; Xiao X; Wang Z; Martari M; Salvatori R J Endocrinol; 2008 Jan; 196(1):79-88. PubMed ID: 18180319 [TBL] [Abstract][Full Text] [Related]
16. Incretins and other peptides in the treatment of diabetes. Todd JF; Bloom SR Diabet Med; 2007 Mar; 24(3):223-32. PubMed ID: 17263764 [TBL] [Abstract][Full Text] [Related]
17. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter. He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073 [TBL] [Abstract][Full Text] [Related]
18. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1). Yu Z; Jin T Cell Signal; 2010 Jan; 22(1):1-8. PubMed ID: 19772917 [TBL] [Abstract][Full Text] [Related]
19. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. Hsu PY; Yang YW J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397 [TBL] [Abstract][Full Text] [Related]
20. Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes. Jean M; Alameh M; Buschmann MD; Merzouki A Gene Ther; 2011 Aug; 18(8):807-16. PubMed ID: 21412280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]